ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Home - FI zu neo-angin® dolo Lutschtabletten/neo-angin® dolo orange Lutschtabletten/neo-angin® dolo Spray, Spray zur Anwendung in der Mundhöhle
Fachinformation zu neo-angin® dolo Lutschtabletten/neo-angin® dolo orange Lutschtabletten/neo-angin® dolo Spray, Spray zur Anwendung in der Mundhöhle:Doetsch Grether AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
R02AX01 - FlurbiprofenATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R02 - Throat Preparations
 
R02A - Throat Preparations

Throat preparations and mouth preparations are classified in the groups R02 and A01 according to assumed main therapeutic use. Preparations used in common minor infections of mouth and throat are classified in R02, while preparations used in gingivitis, stomatitis etc. are classified in A01 - Stomatological preparations.
Preparations for the treatment of symptoms both in mouth and throat are classified in R02 - Throat preparations.

The DDDs are based on the treatment of common minor infections of mouth and throat. For combination products, DDDs are given as fixed doses of 6 UD (6 tablets).

R02AX - Other Throat Preparations

Combinations of benzydamine and cetylpyridinium are classified at the same 5th level as benzydamine.

The DDD for flurbiprofen is based on lozenges and mouth spray which have equivalent dose recommendations.

R02AX01 - Flurbiprofen
StärkeAdm.RouteNote
 O 
 
Arzneimittel A-Z | ATC-Browser | Neuregistrierungen
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home